{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:31:10Z","timestamp":1782811870372,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of the present study was to describe the characteristics of infections with Staphylococcus aureus with reduced vancomycin susceptibility (SARVS) including vancomycin-intermediate S. aureus (VISA) in South Korea, using data from the national sentinel surveillance system during 2014\u20132016. A total of 66 patients infected or colonized with SA-RVS were reported using the sentinel surveillance system. Among them, VISA was confirmed in 14 isolates (21.2%) and no vancomycin-resistant S. aureus (VRSA) was detected. Most of patients had any kind of indwelling devices (81.8%, 54\/66) and underwent surgical procedures in the previous 6 months (84.8%, 56\/66). Patients who admitted to an intensive care unit (ICU) in the previous 3 months were 68.2% (45\/66). Furthermore, patients who used vancomycin or had MRSA in the previous 1 month were 54.5% (36\/66) and 59.1% (39\/66), respectively. Upon review of the medical records, 54.5% (36\/66) of patients were classified as having SA-RVSassociated infection and 30-day mortality was 19.4% (7\/36). Our findings revealed that there was no VRSA in South Korea. SA-RVS including VISA existed particularly in patients who had indwelling devices, history of surgical procedure, and history of ICU admission.<\/jats:p>","DOI":"10.1038\/s41598-019-42307-6","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T10:14:19Z","timestamp":1555496059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea"],"prefix":"10.1038","volume":"9","author":[{"given":"Jung Wan","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3478-3704","authenticated-orcid":false,"given":"Hyungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-6597","authenticated-orcid":false,"given":"Bongyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"42307_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1086\/524891","volume":"46","author":"B Spellberg","year":"2008","unstructured":"Spellberg, B. et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 46, 155\u2013164 (2008).","journal-title":"Clin Infect Dis."},{"key":"42307_CR2","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1086\/499406","volume":"42","author":"SE Cosgrove","year":"2006","unstructured":"Cosgrove, S. E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 42, S82\u2013S89 (2006).","journal-title":"Clin Infect Dis."},{"key":"42307_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/AAC.01169-07","volume":"52","author":"CG Giske","year":"2008","unstructured":"Giske, C. G., Monnet, D. L., Cars, O. & Carmeli, Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 52, 813\u2013821 (2008).","journal-title":"Antimicrob Agents Chemother."},{"key":"42307_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/605630","volume":"49","author":"RR Roberts","year":"2009","unstructured":"Roberts, R. R. et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin infect Dis. 49, 1175\u20131184 (2009).","journal-title":"Clin infect Dis."},{"key":"42307_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.5124\/jkma.2010.53.11.999","volume":"53","author":"J-H Song","year":"2010","unstructured":"Song, J.-H. & Joo, E.-J. The crisis of antimicrobial resistance: current status and future strategies. J Korean Med Assoc. 53, 999\u20131005 (2010).","journal-title":"J Korean Med Assoc."},{"key":"42307_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3343\/alm.2017.37.3.231","volume":"37","author":"D Kim","year":"2017","unstructured":"Kim, D. et al. Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015. Ann Lab Med. 37, 231\u2013239, https:\/\/doi.org\/10.3343\/alm.2017.37.3.231 (2017).","journal-title":"Ann Lab Med."},{"key":"42307_CR7","unstructured":"Korea Centers for Disease Control and Prevention. 2015 annual report from Korean antimicrobial resistance monitoring system [cited 2018 February 14], http:\/\/cdc.go.kr\/CDC\/cms\/cmsFileDownload.jsp?fid=76&cid=71295&fieldName=attachGrp&index=2 (2015)."},{"key":"42307_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4266\/kjccm.2016.00731","volume":"32","author":"JY Lee","year":"2016","unstructured":"Lee, J. Y. et al. Outbreak of Imipenemase-1-Producing Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit. Korean J Crit Care Med. 32, 29\u201338 (2016).","journal-title":"Korean J Crit Care Med."},{"key":"42307_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/JCM.40.4.1376-1380.2002","volume":"40","author":"M-N Kim","year":"2002","unstructured":"Kim, M.-N., Hwang, S. H., Pyo, Y.-J., Mun, H.-M. & Pai, C. H. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol. 40, 1376\u20131380 (2002).","journal-title":"J Clin Microbiol."},{"key":"42307_CR10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","volume":"38","author":"MC Enright","year":"2000","unstructured":"Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J. & Spratt, B. G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones ofStaphylococcus aureus. J Clin Microbiol. 38, 1008\u20131015 (2000).","journal-title":"J Clin Microbiol."},{"key":"42307_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/AAC.46.7.2155-2161.2002","volume":"46","author":"DC Oliveira","year":"2002","unstructured":"Oliveira, D. C. & de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 46, 2155\u20132161 (2002).","journal-title":"Antimicrob Agents Chemother."},{"key":"42307_CR12","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1128\/JCM.41.12.5442-5448.2003","volume":"41","author":"D Harmsen","year":"2003","unstructured":"Harmsen, D. et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 41, 5442\u20135448 (2003).","journal-title":"J Clin Microbiol."},{"key":"42307_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1128\/JCM.42.2.792-799.2004","volume":"42","author":"L Koreen","year":"2004","unstructured":"Koreen, L. et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro-and macrovariation. J Clin Microbiol. 42, 792\u2013799 (2004).","journal-title":"J Clin Microbiol."},{"key":"42307_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1086\/527392","volume":"46","author":"DM Sievert","year":"2008","unstructured":"Sievert, D. M. et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002\u20132006. Clin Infect Dis. 46, 668\u2013674 (2008).","journal-title":"Clin Infect Dis."},{"key":"42307_CR15","doi-asserted-by":"publisher","first-page":"e00112","DOI":"10.1128\/mBio.00112-12","volume":"3","author":"VN Kos","year":"2012","unstructured":"Kos, V. N. et al. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States. MBio 3, e00112\u201300112 (2012).","journal-title":"MBio"},{"key":"42307_CR16","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 15th informational supplement. CLSI document M100-S15 [cited 2018 February 14], http:\/\/www.facm.ucl.ac.be\/intranet\/CLSI\/CLSI-2017-M100-S27.pdf (2017)."},{"key":"42307_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan, T. C., Andrus, M. & Dudeck, M. A. CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting. Am. J Inf Control 36, 309\u2013332 (2008).","journal-title":"J Inf Control"},{"key":"42307_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa025025","volume":"348","author":"S Chang","year":"2003","unstructured":"Chang, S. et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Eng J Med. 348, 1342\u20131347, https:\/\/doi.org\/10.1056\/NEJMoa025025 (2003).","journal-title":"N Eng J Med."},{"key":"42307_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1086\/422458","volume":"39","author":"SE Cosgrove","year":"2004","unstructured":"Cosgrove, S. E., Carroll, K. C. & Perl, T. M. Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infec Dis. 39, 539\u2013545, https:\/\/doi.org\/10.1086\/422458 (2004).","journal-title":"Clin Infec Dis."},{"key":"42307_CR20","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1172\/JCI68834","volume":"124","author":"S Gardete","year":"2014","unstructured":"Gardete, S. & Tomasz, A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest. 124, 2836 (2014).","journal-title":"J Clin Invest."},{"key":"42307_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.micro.56.012302.160806","volume":"56","author":"TR Walsh","year":"2002","unstructured":"Walsh, T. R. & Howe, R. A. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann Rev Microbiol. 56, 657\u2013675 (2002).","journal-title":"Ann Rev Microbiol."},{"key":"42307_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1086\/346207","volume":"36","author":"SK Fridkin","year":"2003","unstructured":"Fridkin, S. K. et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001. Clin Infect Dis. 36, 429\u2013439 (2003).","journal-title":"Clin Infect Dis."},{"key":"42307_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dkn329","volume":"62","author":"TP Lodise","year":"2008","unstructured":"Lodise, T. P. et al. Predictors of high vancomycin MIC values among patients with mehticillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 62, 1138\u20131141 (2008).","journal-title":"J Antimicrob Chemother"},{"key":"42307_CR24","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","volume":"17","author":"JT Jacob","year":"2013","unstructured":"Jacob, J. T. & DiazGranados, C. A. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistnat Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17, e93\u2013e100 (2013).","journal-title":"Int J Infect Dis"},{"key":"42307_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ van Hal","year":"2012","unstructured":"van Hal, S. J., Lodise, T. P. & Paterson, D. L. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-anaylsis. Clin Infect Dis 54, 755\u2013771 (2012).","journal-title":"Clin Infect Dis"},{"key":"42307_CR26","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil, A. C., Van Schooneveld, T. C., Fey, P. D. & Rupp, M. E. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. Jama 312, 1552\u20131564 (2014).","journal-title":"Jama"},{"key":"42307_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3904\/kjim.2016.351","volume":"34","author":"T Kim","year":"2019","unstructured":"Kim, T. et al. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia. Korean J Intern Med 34, 184\u2013194 (2019).","journal-title":"Korean J Intern Med"},{"key":"42307_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","volume":"1","author":"K Hiramatsu","year":"2001","unstructured":"Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 1, 147\u2013155 (2001).","journal-title":"Lancet Infect Dis."},{"key":"42307_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/jac\/dkr066","volume":"66","author":"PG Kelley","year":"2011","unstructured":"Kelley, P. G., Gao, W., Ward, P. B. & Howden, B. P. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother. 66, 1057\u20131060 (2011).","journal-title":"J Antimicrob Chemother."},{"key":"42307_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui, L., Tominaga, E., Neoh, H.-M. & Hiramatsu, K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 50, 1079\u20131082 (2006).","journal-title":"Antimicrob Agents Chemother."},{"key":"42307_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","volume":"50","author":"G Sakoulas","year":"2006","unstructured":"Sakoulas, G., Alder, J., Thauvin-Eliopoulos, C., Moellering, R. C. & Eliopoulos, G. M. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother. 50, 1581\u20131585 (2006).","journal-title":"Antimicrob Agents Chemother."},{"key":"42307_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJM199902183400704","volume":"340","author":"K Sieradzki","year":"1999","unstructured":"Sieradzki, K., Roberts, R. B., Haber, S. W. & Tomasz, A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med. 340, 517\u2013523 (1999).","journal-title":"N Engl J Med."},{"key":"42307_CR33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","volume":"43","author":"MW Climo","year":"1999","unstructured":"Climo, M. W., Patron, R. L. & Archer, G. L. Combinations of vancomycin and \u03b2-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob Agents Chemother. 43, 1747\u20131753 (1999).","journal-title":"Antimicrob Agents Chemother."},{"key":"42307_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3947\/ic.2017.49.2.109","volume":"49","author":"E-J Joo","year":"2017","unstructured":"Joo, E.-J. et al. Emergence of Community-Genotype Methicillin-Resistant Staphylococcus aureus in Korean Hospitals: Clinical Characteristics of Nosocomial Infections by Community-Genotype Strain. Infect Chemother. 49, 109\u2013116 (2017).","journal-title":"Infect Chemother."},{"key":"42307_CR35","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.43.7.3435-3437.2005","volume":"43","author":"PDA Trindade","year":"2005","unstructured":"Trindade, P. D. A. et al. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 43, 3435\u20133437 (2005).","journal-title":"J Clin Microbiol."},{"key":"42307_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3201\/eid0908.030089","volume":"9","author":"F Vandenesch","year":"2003","unstructured":"Vandenesch, F. et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 9, 978 (2003).","journal-title":"Emerg Infect Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42307-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:54:32Z","timestamp":1671267272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42307-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42307"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42307-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6236"}}